BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17696333)

  • 1. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
    Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
    J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.
    Babaoglu K; Qi J; Lee RE; White SW
    Structure; 2004 Sep; 12(9):1705-17. PubMed ID: 15341734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.
    Bennett BC; Wan Q; Ahmad MF; Langan P; Dealwis CG
    J Struct Biol; 2009 May; 166(2):162-71. PubMed ID: 19374017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
    Cody V; Luft JR; Pangborn W
    Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
    Barrow EW; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
    Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
    J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships.
    Beierlein JM; Karri NG; Anderson AC
    J Med Chem; 2010 Oct; 53(20):7327-36. PubMed ID: 20882962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the BcZBP, a zinc-binding protein from Bacillus cereus.
    Fadouloglou VE; Deli A; Glykos NM; Psylinakis E; Bouriotis V; Kokkinidis M
    FEBS J; 2007 Jun; 274(12):3044-54. PubMed ID: 17501983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region.
    Summerfield RL; Daigle DM; Mayer S; Mallik D; Hughes DW; Jackson SG; Sulek M; Organ MG; Brown ED; Junop MS
    J Med Chem; 2006 Nov; 49(24):6977-86. PubMed ID: 17125251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
    de Beer TA; Louw AI; Joubert F
    Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
    Joska TM; Anderson AC
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
    Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
    Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the conformation of trimethoprim in the binding pocket of bovine dihydrofolate reductase from a STD-NMR intensity-restrained CORCEMA-ST optimization.
    Jayalakshmi V; Krishna NR
    J Am Chem Soc; 2005 Oct; 127(40):14080-4. PubMed ID: 16201830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling toward selective inhibitors of dihydrofolate reductase from the biological warfare agent Bacillus anthracis.
    Giacoppo JO; Mancini DT; Guimarães AP; Gonçalves AS; da Cunha EF; França TC; Ramalho TC
    Eur J Med Chem; 2015 Feb; 91():63-71. PubMed ID: 24985033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase.
    Beierlein JM; Frey KM; Bolstad DB; Pelphrey PM; Joska TM; Smith AE; Priestley ND; Wright DL; Anderson AC
    J Med Chem; 2008 Dec; 51(23):7532-40. PubMed ID: 19007108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural adaptation of an interacting non-native C-terminal helical extension revealed in the crystal structure of NAD+ synthetase from Bacillus anthracis.
    McDonald HM; Pruett PS; Deivanayagam C; Protasevich II; Carson WM; DeLucas LJ; Brouillette WJ; Brouillette CG
    Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):891-905. PubMed ID: 17642516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
    Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
    Cody V; Pace J; Chisum K; Rosowsky A
    Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.